about
Iprindole: a cornerstone in the neurobiological investigation of antidepressant treatmentsPositive and negative symptoms: historical and conceptual aspects.Relationship of genetic factors to course and drug response in schizophrenia, mania and depression.Alcoholism: a pharmacogenetic disorder.Genetics of monoamine oxidase.Monoamine oxidase. Its inhibition.Cytogenetic effects of psychoactive drugs.Two weeks' treatment with chlorpromazine, thioridazine, sulpiride, or bromazepam: actions and interactions with alcohol on psychomotor skills related to driving.Social phobia.Neurochemical and neural mechanisms of positive and negative symptoms in schizophrenia.AMDP anamnestic data: foundations, structure and functions.Evidence for the validity of negative symptoms.Relationship between brain imaging findings in schizophrenia and psychopathology. A review of the literature relating to positive and negative symptoms.Effects of sedatives and major tranquilizers on aggressive behavior.Pharmacological management of human violence.Effects of stimulants on aggressive behavior.Pharmacological profile of ateroid.Diagnosis of the dementias.Neurotransmitter systems and receptor plasticity in brain aging.Concerning semantic problems in psychological evaluation.Content analysis of 27 anxiety inventories and rating scales.Introduction to the diagnosis and treatment of old age dementias.Neuroimaging in the diagnosis of old age dementias.Neurophysiological aspects of aging and gerontopsychopharmacology.Structure and biological activity of mammalian glycosaminoglycans.Clinical differences between anxiolytics and sedatives.Differential psychopharmacology of tranquilizing and sedating drugs.Effect of sedatives and anxiolytics on aggressivity.Neuropharmacology of sedatives and anxiolytics.Behavioral studies to differentiate anxiolytic and sedative activity of the tranquilizing drugs.Methods for the assessment of psychotropic drug effects in healthy volunteers. A critical review.Narcotic analgesics and aggression.Antidepressants and aggressive behavior.The effect of lithium and other ions on aggressive behavior.Effects of cannabinoid compounds on aggressive behavior.Effects of psychodysleptics on aggressive behavior of animals.NOSIE--30: history and current status of its use in pharmacopsychiatric research.The Hopkins Symptom Checklist (HSCL). A measure of primary symptom dimensions.The Middlesex Hospital Questionnaire (MHQ) in clinical research. A review.The WPRS: a quantification of observable psychopathology.
P1433
Q28264703-A0D6E76A-C316-4CD5-AA03-8E69F6FEC4CDQ34028249-C18A1016-9FF2-4EDC-9C42-C736BB73DD40Q34048492-C1ED01A6-3040-4F38-B7A4-D6744EA71465Q34048510-9A989B7F-53E5-4A18-92FB-048F4D051988Q34048523-724FA729-1EED-4039-A918-71DD79A573A3Q34048533-E54E8262-860B-433B-BEAB-B474BB245E75Q34048539-A105CAB2-1D55-42A8-B74D-66F8987B581CQ34467510-64A83051-D7E7-4D54-B4E9-C99CEC480251Q34559590-52916617-3391-4229-861D-F0FFF6F8129CQ34999593-267288FD-C165-4A93-A4B8-078D7096E5ECQ36617505-54841E42-76D3-4236-B859-35734DFEDA3BQ37921528-1ED99918-E168-41CB-91BD-C4BEA5E1D064Q37921532-F5330EEB-BEDA-40C9-A32D-DABD92A5F29CQ38156507-60BB654D-5E79-4C4D-9B0A-808720465842Q38156602-C5AAB77D-835C-4BA1-9209-285BACB3D828Q38156693-771E84FC-005E-470B-9A71-A682D2DE740CQ38202005-5E1DAEB0-E10E-4C09-BC41-2DEF7FBBEA54Q38252781-D2903340-CFC5-463A-9CFE-400E9611D68EQ38347565-883E32A7-E962-4031-82B0-5B09BE0DF151Q38507011-141195D8-7C9E-4B5C-8571-ACA7FC1BBBC8Q38507099-FBB51125-FBD8-4067-AFAA-0A9157BF9222Q38627426-C606F3B6-8A9F-4827-97CD-626F78B0BACDQ38627435-BB0F180F-0487-42E8-9506-DEAE166004B0Q38627437-345D1004-6BFB-4572-875A-92883F07F1F7Q38627442-887BE65C-B744-4AFF-B794-2739E9077274Q39234894-307315CC-BA4E-4AB7-82C5-D04DC3018427Q39234899-D4447E23-4EBE-4E59-96A7-1D0C603DA63CQ39234905-9A26D5A9-0B05-4897-8F3E-776CCFC8845CQ39234910-CCF33188-1420-46D3-9EF6-419F17B2EB81Q39234915-529987F9-54C9-4F20-A5CF-CE724DAAC83FQ39703945-FA93F5F3-5653-456E-8B8A-1A146179B1BEQ39717069-EEC8AFA9-1E33-4438-92F5-225ADBA54CA2Q39717074-48EF2336-1C81-4F3F-A960-3BA25D5870E8Q39717079-A99B2968-EB01-4449-9029-0118213C4DE5Q39717084-6DCC7A31-6865-4DAD-B881-A3840A2DEC11Q39874448-1681B5DF-E3B7-453F-9A89-61302A2859E3Q39946148-FCEE7883-55FB-4259-BC48-AA6F8781ADF4Q39946534-E0728B34-3987-43C8-8469-99265F801CDCQ39946540-BF97439C-D73B-47CA-A0DF-B86A845F7833Q39946550-8A583290-545A-4D8C-A796-CF78FCF3F8FF
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Karger Publishers
@nl
wissenschaftliche Fachzeitschrift
@de
name
Modern problems of pharmacopsychiatry
@ast
Modern problems of pharmacopsychiatry
@en
Modern problems of pharmacopsychiatry
@es
Modern problems of pharmacopsychiatry
@it
Modern problems of pharmacopsychiatry
@nl
type
label
Modern problems of pharmacopsychiatry
@ast
Modern problems of pharmacopsychiatry
@en
Modern problems of pharmacopsychiatry
@es
Modern problems of pharmacopsychiatry
@it
Modern problems of pharmacopsychiatry
@nl
altLabel
Mod Probl Pharmacopsychiatry
@en
prefLabel
Modern problems of pharmacopsychiatry
@ast
Modern problems of pharmacopsychiatry
@en
Modern problems of pharmacopsychiatry
@es
Modern problems of pharmacopsychiatry
@it
Modern problems of pharmacopsychiatry
@nl
P1055
P1156
P1476
Modern problems of pharmacopsychiatry
@en